BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 17713119)

  • 1. [Molecular genetics of PINK1].
    Funayama M; Hattori N
    Brain Nerve; 2007 Aug; 59(8):831-8. PubMed ID: 17713119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
    Dodson MW; Guo M
    Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
    van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
    Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.
    Weihofen A; Ostaszewski B; Minami Y; Selkoe DJ
    Hum Mol Genet; 2008 Feb; 17(4):602-16. PubMed ID: 18003639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1).
    Mills RD; Sim CH; Mok SS; Mulhern TD; Culvenor JG; Cheng HC
    J Neurochem; 2008 Apr; 105(1):18-33. PubMed ID: 18221368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
    Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
    Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parkin and mitochondria].
    Mitsui T; Kuroda Y; Kaji R
    Brain Nerve; 2008 Aug; 60(8):923-9. PubMed ID: 18717196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease.
    Tang B; Xiong H; Sun P; Zhang Y; Wang D; Hu Z; Zhu Z; Ma H; Pan Q; Xia JH; Xia K; Zhang Z
    Hum Mol Genet; 2006 Jun; 15(11):1816-25. PubMed ID: 16632486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy.
    Thomas KJ; McCoy MK; Blackinton J; Beilina A; van der Brug M; Sandebring A; Miller D; Maric D; Cedazo-Minguez A; Cookson MR
    Hum Mol Genet; 2011 Jan; 20(1):40-50. PubMed ID: 20940149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis for DJ-1 in sporadic and familial parkinsonism: screening strategy in parkinsonism.
    Tomiyama H; Li Y; Yoshino H; Mizuno Y; Kubo S; Toda T; Hattori N
    Neurosci Lett; 2009 May; 455(3):159-61. PubMed ID: 19429112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of recent genetic findings in Parkinson's disease.
    Klein C; Lohmann-Hedrich K
    Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
    Klein C; Lohmann-Hedrich K; Rogaeva E; Schlossmacher MG; Lang AE
    Lancet Neurol; 2007 Jul; 6(7):652-62. PubMed ID: 17582365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic mutations and functions of PINK1.
    Kawajiri S; Saiki S; Sato S; Hattori N
    Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.
    Myhre R; Steinkjer S; Stormyr A; Nilsen GL; Abu Zayyad H; Horany K; Nusier MK; Klungland H
    BMC Neurol; 2008 Dec; 8():47. PubMed ID: 19087301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
    Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
    Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.
    Mellick GD; Siebert GA; Funayama M; Buchanan DD; Li Y; Imamichi Y; Yoshino H; Silburn PA; Hattori N
    Parkinsonism Relat Disord; 2009 Feb; 15(2):105-9. PubMed ID: 18486522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.
    Macedo MG; Verbaan D; Fang Y; van Rooden SM; Visser M; Anar B; Uras A; Groen JL; Rizzu P; van Hilten JJ; Heutink P
    Mov Disord; 2009 Jan; 24(2):196-203. PubMed ID: 18973254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.